位置:首页 > 蛋白库 > BGAT_HUMAN
BGAT_HUMAN
ID   BGAT_HUMAN              Reviewed;         354 AA.
AC   P16442; B0JDB9; O14758; Q14490; Q53I57; Q6ISD4; Q6KFZ2; Q70V27; Q99484;
AC   Q99485; Q9NY01; Q9UQ68; Q9UQ69;
DT   01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-1992, sequence version 2.
DT   03-AUG-2022, entry version 222.
DE   RecName: Full=Histo-blood group ABO system transferase;
DE   AltName: Full=Fucosylglycoprotein 3-alpha-galactosyltransferase;
DE   AltName: Full=Fucosylglycoprotein alpha-N-acetylgalactosaminyltransferase;
DE   AltName: Full=Glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase;
DE            EC=2.4.1.40 {ECO:0000269|PubMed:12198488, ECO:0000269|PubMed:17259183};
DE   AltName: Full=Glycoprotein-fucosylgalactoside alpha-galactosyltransferase;
DE            EC=2.4.1.37 {ECO:0000269|PubMed:12198488, ECO:0000269|PubMed:17259183};
DE   AltName: Full=Histo-blood group A transferase;
DE            Short=A transferase;
DE   AltName: Full=Histo-blood group B transferase;
DE            Short=B transferase;
DE   AltName: Full=NAGAT;
DE   Contains:
DE     RecName: Full=Fucosylglycoprotein alpha-N-acetylgalactosaminyltransferase soluble form;
GN   Name=ABO;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PARTIAL PROTEIN SEQUENCE.
RX   PubMed=2104828; DOI=10.1016/s0021-9258(19)40170-1;
RA   Yamamoto F., Marken J., Tsuji T., White T., Clausen H., Hakomori S.;
RT   "Cloning and characterization of DNA complementary to human UDP-GalNAc: Fuc
RT   alpha 1-->2Gal alpha 1-->3GalNAc transferase (histo-blood group A
RT   transferase) mRNA.";
RL   J. Biol. Chem. 265:1146-1151(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2333095; DOI=10.1038/345229a0;
RA   Yamamoto F., Clausen H., White T., Marken J., Hakomori S.;
RT   "Molecular genetic basis of the histo-blood group ABO system.";
RL   Nature 345:229-233(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], POLYMORPHISM, AND VARIANT LEU-156.
RX   PubMed=7598760; DOI=10.1006/bbrc.1995.1044;
RA   Bennett E.P., Steffensen R., Clausen H., Weghuis D.O.,
RA   Geurts van Kessel A.;
RT   "Genomic cloning of the human histo-blood group ABO locus.";
RL   Biochem. Biophys. Res. Commun. 206:318-325(1995).
RN   [4]
RP   ERRATUM OF PUBMED:7598760.
RX   PubMed=7779106; DOI=10.1006/bbrc.1995.1817;
RA   Bennett E.P., Steffensen R., Clausen H., Weghuis D.O.,
RA   Geurts van Kessel A.;
RL   Biochem. Biophys. Res. Commun. 211:347-347(1995).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], POLYMORPHISM, AND VARIANTS
RP   LEU-156; GLY-176; SER-235 AND MET-266.
RA   Yamamoto F.;
RT   "Human histo-blood group ABO gene locus alleles.";
RL   Submitted (MAR-1999) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Peripheral blood;
RX   PubMed=16533287; DOI=10.1111/j.1537-2995.2006.00740.x;
RA   Seltsam A., Das Gupta C., Bade-Doeding C., Blasczyk R.;
RT   "A weak blood group A phenotype caused by a translation-initiator mutation
RT   in the ABO gene.";
RL   Transfusion 46:434-440(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Peripheral blood;
RX   PubMed=17764507; DOI=10.1111/j.1537-2995.2007.01475.x;
RA   Seltsam A., Wagner F.F., Gruger D., Gupta C.D., Bade-Doeding C.,
RA   Blasczyk R.;
RT   "Weak blood group B phenotypes may be caused by variations in the CCAAT-
RT   binding factor/NF-Y enhancer region of the ABO gene.";
RL   Transfusion 47:2330-2335(2007).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], POLYMORPHISM, AND VARIANTS ARG-230;
RP   SER-235; MET-266 AND ALA-268.
RC   TISSUE=Peripheral blood;
RX   PubMed=18513251; DOI=10.1111/j.1537-2995.2008.01782.x;
RA   Seltsam A., Gruger D., Just B., Figueiredo C., Gupta C.D., Deluca D.S.,
RA   Blasczyk R.;
RT   "Aberrant intracellular trafficking of a variant B glycosyltransferase.";
RL   Transfusion 48:1898-1905(2008).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], POLYMORPHISM, AND VARIANTS ARG-35;
RP   PHE-36; HIS-63; SER-74; LEU-156; HIS-161; GLY-176; CYS-199; ILE-216;
RP   SER-235; MET-266; ALA-268 AND MET-277.
RG   SeattleSNPs variation discovery resource;
RL   Submitted (APR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], POLYMORPHISM, AND VARIANTS GLY-176;
RP   SER-235; MET-266 AND ALA-268.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 11-354, POLYMORPHISM, AND VARIANTS
RP   SER-74; LEU-156; MET-163; GLY-176; TRP-198; SER-235; MET-266; ALA-268;
RP   ARG-268; ARG-288 AND MET-346.
RX   PubMed=12829588; DOI=10.1182/blood-2003-03-0955;
RA   Seltsam A., Hallensleben M., Kollmann A., Blasczyk R.;
RT   "The nature of diversity and diversification at the ABO locus.";
RL   Blood 102:3035-3042(2003).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 81-354, POLYMORPHISM, AND VARIANTS
RP   LEU-156; GLY-176; ARG-214; ILE-216; ASP-223; SER-235; MET-266; ALA-268;
RP   MET-277; ASN-291; GLY-352 AND TRP-352.
RX   PubMed=8839869;
RA   Ogasawara K., Yabe R., Uchikawa M., Saitou N., Bannai M., Nakata K.,
RA   Takenaka M., Fujisawa K., Ishikawa Y., Juji T., Tokunaga K.;
RT   "Molecular genetic analysis of variant phenotypes of the ABO blood group
RT   system.";
RL   Blood 88:2732-2737(1996).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 81-354.
RX   PubMed=9800297; DOI=10.1046/j.1365-3148.1998.00161.x;
RA   Olsson M.L., Chester M.A.;
RT   "Heterogeneity of the blood group Ax allele: genetic recombination of
RT   common alleles can result in the Ax phenotype.";
RL   Transfus. Med. 8:231-238(1998).
RN   [14]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 11-354, POLYMORPHISM, AND VARIANTS
RP   GLY-176; SER-235; MET-266 AND ALA-268.
RX   PubMed=15104652; DOI=10.1111/j.1537-2995.2004.03346.x;
RA   Roubinet F., Despiau S., Calafell F., Jin F., Bertanpetit J., Saitou N.,
RA   Blancher A.;
RT   "Evolution of the O alleles of the human ABO blood group gene.";
RL   Transfusion 44:707-715(2004).
RN   [15]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 126-354, POLYMORPHISM, AND VARIANTS
RP   GLY-176; SER-235 AND MET-346.
RA   Seltsam A., Hallensleben M., Salama A., Blasczyk R.;
RT   "A novel B Transferase.";
RL   Submitted (MAR-2000) to the EMBL/GenBank/DDBJ databases.
RN   [16]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 146-334, POLYMORPHISM, AND VARIANTS
RP   MET-266 AND ALA-268.
RX   PubMed=1449469; DOI=10.1016/0006-291x(92)91538-2;
RA   Kominato Y., McNeill P.D., Yamamoto M., Russell M., Hakomori S.,
RA   Yamamoto F.;
RT   "Animal histo-blood group ABO genes.";
RL   Biochem. Biophys. Res. Commun. 189:154-164(1992).
RN   [17]
RP   CHARACTERIZATION, AND POLYMORPHISM.
RX   PubMed=2121736; DOI=10.1016/s0021-9258(17)30652-x;
RA   Yamamoto F., Hakomori S.;
RT   "Sugar-nucleotide donor specificity of histo-blood group A and B
RT   transferases is based on amino acid substitutions.";
RL   J. Biol. Chem. 265:19257-19262(1990).
RN   [18]
RP   POLYMORPHISM, AND VARIANT ALA-234.
RX   PubMed=10462501; DOI=10.1006/bbrc.1999.1246;
RA   Yu L.C., Lee H.L., Chan Y.S., Lin M.;
RT   "The molecular basis for the B(A) allele: an amino acid alteration in the
RT   human histoblood group B alpha-(1,3)-galactosyltransferase increases its
RT   intrinsic alpha-(1,3)-N-acetylgalactosaminyltransferase activity.";
RL   Biochem. Biophys. Res. Commun. 262:487-493(1999).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (1.35 ANGSTROMS) OF 64-354 IN COMPLEX WITH MANGANESE
RP   AND UDP-N-ACETYL-D-GALACTOSAMINE, METAL-BINDING, MUTAGENESIS OF GLU-303,
RP   AND CATALYTIC ACTIVITY.
RX   PubMed=12198488; DOI=10.1038/nsb832;
RA   Patenaude S.I., Seto N.O.L., Borisova S.N., Szpacenko A., Marcus S.L.,
RA   Palcic M.M., Evans S.V.;
RT   "The structural basis for specificity in human ABO(H) blood group
RT   biosynthesis.";
RL   Nat. Struct. Biol. 9:685-690(2002).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (1.55 ANGSTROMS) OF 64-345 OF MUTANT SER-234 IN
RP   COMPLEX WITH GLYCOPROTEIN FUCOSYL-GALACTOSE ANALOG.
RX   PubMed=12529355; DOI=10.1074/jbc.m212002200;
RA   Marcus S.L., Polakowski R., Seto N.O.L., Leinala E., Borisova S.,
RA   Blancher A., Roubinet F., Evans S.V., Palcic M.M.;
RT   "A single point mutation reverses the donor specificity of human blood
RT   group B-synthesizing galactosyltransferase.";
RL   J. Biol. Chem. 278:12403-12405(2003).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (1.55 ANGSTROMS) OF 64-345 IN COMPLEXES WITH
RP   MANGANESE; UDP; UDP-N-ACETYL-GALACTOSAMINE; UDP-GALACTOSE AND GLYCOPROTEIN
RP   FUCOSYL-GALACTOSE ANALOGS.
RX   PubMed=12972418; DOI=10.1074/jbc.m308770200;
RA   Nguyen H.P., Seto N.O.L., Cai Y., Leinala E.K., Borisova S.N., Palcic M.M.,
RA   Evans S.V.;
RT   "The influence of an intramolecular hydrogen bond in differential
RT   recognition of inhibitory acceptor analogs by human ABO(H) blood group A
RT   and B glycosyltransferases.";
RL   J. Biol. Chem. 278:49191-49195(2003).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (1.49 ANGSTROMS) OF 64-354 OF MUTANTS SER-74 AND
RP   ARG-268 IN COMPLEXES WITH GLYCOPROTEIN FUCOSYL-GALACTOSE ANALOG AND
RP   UDP-N-ACETYL-GALACTOSAMINE.
RX   PubMed=15475562; DOI=10.1074/jbc.m500897200;
RA   Lee H.J., Barry C.H., Borisova S.N., Seto N.O.L., Zheng R.B., Blancher A.,
RA   Evans S.V., Palcic M.M.;
RT   "Structural basis for the inactivity of human blood group O2
RT   glycosyltransferase.";
RL   J. Biol. Chem. 280:525-529(2005).
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (1.49 ANGSTROMS) OF 64-354 OF HISTO-BLOOD GROUP A
RP   TRANSFERASE AND HISTO-BLOOD GROUP B TRANSFERASE IN COMPLEX WITH MANGANESE
RP   AND GLYCOPROTEIN FUCOSYL-GALACTOSE ANALOGS.
RX   PubMed=16326711; DOI=10.1074/jbc.m507620200;
RA   Letts J.A., Rose N.L., Fang Y.R., Barry C.H., Borisova S.N., Seto N.O.L.,
RA   Palcic M.M., Evans S.V.;
RT   "Differential recognition of the type I and II H antigen acceptors by the
RT   human ABO(H) blood group A and B glycosyltransferases.";
RL   J. Biol. Chem. 281:3625-3632(2006).
RN   [24]
RP   X-RAY CRYSTALLOGRAPHY (1.67 ANGSTROMS) OF 64-354 OF MUTANTS ARG-214 AND
RP   THR-214, COFACTOR, CHARACTERIZATION OF VARIANT ARG-214, MUTAGENESIS OF
RP   MET-214, AND CATALYTIC ACTIVITY.
RX   PubMed=17259183; DOI=10.1074/jbc.m610998200;
RA   Persson M., Letts J.A., Hosseini-Maaf B., Borisova S.N., Palcic M.M.,
RA   Evans S.V., Olsson M.L.;
RT   "Structural effects of naturally occurring human blood group B
RT   galactosyltransferase mutations adjacent to the DXD motif.";
RL   J. Biol. Chem. 282:9564-9570(2007).
CC   -!- FUNCTION: This protein is the basis of the ABO blood group system. The
CC       histo-blood group ABO involves three carbohydrate antigens: A, B, and
CC       H. A, B, and AB individuals express a glycosyltransferase activity that
CC       converts the H antigen to the A antigen (by addition of UDP-GalNAc) or
CC       to the B antigen (by addition of UDP-Gal), whereas O individuals lack
CC       such activity.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an alpha-L-fucosyl-(1->2)-beta-D-galactosyl derivative + UDP-
CC         N-acetyl-alpha-D-galactosamine = an N-acetyl-alpha-D-galactosaminyl-
CC         (1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl derivative + H(+) +
CC         UDP; Xref=Rhea:RHEA:19021, ChEBI:CHEBI:15378, ChEBI:CHEBI:58223,
CC         ChEBI:CHEBI:67138, ChEBI:CHEBI:140327, ChEBI:CHEBI:140559;
CC         EC=2.4.1.40; Evidence={ECO:0000269|PubMed:12198488,
CC         ECO:0000269|PubMed:17259183};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an alpha-L-fucosyl-(1->2)-beta-D-galactosyl derivative + UDP-
CC         alpha-D-galactose = an alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-
CC         (1->2)]-beta-D-galactosyl derivative + H(+) + UDP;
CC         Xref=Rhea:RHEA:14349, ChEBI:CHEBI:15378, ChEBI:CHEBI:58223,
CC         ChEBI:CHEBI:66914, ChEBI:CHEBI:140327, ChEBI:CHEBI:140328;
CC         EC=2.4.1.37; Evidence={ECO:0000269|PubMed:12198488,
CC         ECO:0000269|PubMed:17259183};
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000269|PubMed:17259183};
CC       Note=Binds 1 Mn(2+) ion per subunit. {ECO:0000269|PubMed:17259183};
CC   -!- PATHWAY: Protein modification; protein glycosylation. {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus, Golgi stack membrane; Single-
CC       pass type II membrane protein. Secreted. Note=Membrane-bound form in
CC       trans cisternae of Golgi. Secreted into the body fluid.
CC   -!- DOMAIN: The conserved DXD motif is involved in cofactor binding. The
CC       manganese ion interacts with the beta-phosphate group of UDP and may
CC       also have a role in catalysis.
CC   -!- PTM: The soluble form derives from the membrane form by proteolytic
CC       processing.
CC   -!- POLYMORPHISM: Genetic variations in ABO define the ABO blood group
CC       system [MIM:616093]. The ABO blood group system is the most important
CC       blood group system in blood transfusion. The sequence shown here is
CC       that of the A transferase. The B form differs by a few residues
CC       substitution. Residues 266 and 268 are important for specificity. The
CC       reference genome assembly (GRCh38/hg38) describes a non-functional O-
CC       type ABO allele. The O-type ABO allele results in a guanine deletion
CC       (NM_020469.2: c.286delG). This deletion induces a frameshift and
CC       creates a premature stop codon resulting in a truncated (117 amino
CC       acids) protein deprived of any glycosyltransferase activity
CC       (PubMed:2333095). {ECO:0000269|PubMed:10462501,
CC       ECO:0000269|PubMed:12829588, ECO:0000269|PubMed:1449469,
CC       ECO:0000269|PubMed:15104652, ECO:0000269|PubMed:15489334,
CC       ECO:0000269|PubMed:18513251, ECO:0000269|PubMed:2121736,
CC       ECO:0000269|PubMed:2333095, ECO:0000269|PubMed:7598760,
CC       ECO:0000269|PubMed:8839869, ECO:0000269|Ref.15, ECO:0000269|Ref.5,
CC       ECO:0000269|Ref.9}.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 6 family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/abo/";
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - GTase; Note=Histo-
CC       blood group ABO system transferase;
CC       URL="http://www.functionalglycomics.org/glycomics/molecule/jsp/glycoEnzyme/viewGlycoEnzyme.jsp?gbpId=gt_hum_450";
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - GTase; Note=Histo-
CC       blood group ABO system transferase;
CC       URL="http://www.functionalglycomics.org/glycomics/molecule/jsp/glycoEnzyme/viewGlycoEnzyme.jsp?gbpId=gt_hum_502";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; J05175; AAA36792.1; -; mRNA.
DR   EMBL; X84746; CAA59233.1; -; Genomic_DNA.
DR   EMBL; X84747; CAA59233.1; JOINED; Genomic_DNA.
DR   EMBL; X84748; CAA59233.1; JOINED; Genomic_DNA.
DR   EMBL; X84749; CAA59233.1; JOINED; Genomic_DNA.
DR   EMBL; X84750; CAA59233.1; JOINED; Genomic_DNA.
DR   EMBL; X84751; CAA59233.1; JOINED; Genomic_DNA.
DR   EMBL; X84752; CAA59233.1; JOINED; Genomic_DNA.
DR   EMBL; AF134412; AAD26572.1; -; mRNA.
DR   EMBL; AF134413; AAD26573.1; -; mRNA.
DR   EMBL; AF134414; AAD26574.1; -; mRNA.
DR   EMBL; AH007586; AAD26575.1; -; Genomic_DNA.
DR   EMBL; AH007587; AAD26576.1; -; Genomic_DNA.
DR   EMBL; AH007592; AAD26581.1; -; Genomic_DNA.
DR   EMBL; AJ920329; CAI79116.1; -; Genomic_DNA.
DR   EMBL; AM423110; CAM28424.1; -; Genomic_DNA.
DR   EMBL; AM492698; CAM34526.1; -; Genomic_DNA.
DR   EMBL; AM492699; CAM34527.1; -; Genomic_DNA.
DR   EMBL; AY268591; AAP03430.1; -; Genomic_DNA.
DR   EMBL; BC069595; AAH69595.1; -; mRNA.
DR   EMBL; BC111575; AAI11576.1; -; mRNA.
DR   EMBL; AJ536135; CAD60222.1; -; Genomic_DNA.
DR   EMBL; AJ536136; CAD60223.1; -; Genomic_DNA.
DR   EMBL; D82842; BAA11591.2; -; Genomic_DNA.
DR   EMBL; D82843; BAA11592.2; -; Genomic_DNA.
DR   EMBL; AF016622; AAB86462.1; -; Genomic_DNA.
DR   EMBL; AF448199; AAQ04662.1; -; Genomic_DNA.
DR   EMBL; AF448200; AAQ04663.1; -; Genomic_DNA.
DR   EMBL; AJ276689; CAB81779.1; -; Genomic_DNA.
DR   PIR; PC1165; PC1165.
DR   RefSeq; NP_065202.2; NM_020469.2.
DR   PDB; 1LZ0; X-ray; 1.80 A; A=64-354.
DR   PDB; 1LZ7; X-ray; 1.65 A; A=64-354.
DR   PDB; 1LZI; X-ray; 1.35 A; A=64-354.
DR   PDB; 1LZJ; X-ray; 1.32 A; A=64-354.
DR   PDB; 1R7T; X-ray; 2.09 A; A=64-345.
DR   PDB; 1R7U; X-ray; 1.61 A; A=64-345.
DR   PDB; 1R7V; X-ray; 2.09 A; A=64-345.
DR   PDB; 1R7X; X-ray; 1.97 A; A=64-345.
DR   PDB; 1R7Y; X-ray; 1.75 A; A=64-345.
DR   PDB; 1R80; X-ray; 1.65 A; A=64-345.
DR   PDB; 1R81; X-ray; 1.75 A; A=64-345.
DR   PDB; 1R82; X-ray; 1.55 A; A=64-345.
DR   PDB; 1WSZ; X-ray; 1.59 A; A=64-354.
DR   PDB; 1WT0; X-ray; 1.80 A; A=64-354.
DR   PDB; 1WT1; X-ray; 1.55 A; A=64-354.
DR   PDB; 1WT2; X-ray; 1.90 A; A=64-354.
DR   PDB; 1WT3; X-ray; 1.80 A; A=64-354.
DR   PDB; 1XZ6; X-ray; 1.55 A; A=64-354.
DR   PDB; 1ZHJ; X-ray; 1.59 A; A=64-354.
DR   PDB; 1ZI1; X-ray; 1.57 A; A=64-354.
DR   PDB; 1ZI3; X-ray; 1.69 A; A=64-354.
DR   PDB; 1ZI4; X-ray; 1.85 A; A=64-354.
DR   PDB; 1ZI5; X-ray; 1.55 A; A=64-354.
DR   PDB; 1ZIZ; X-ray; 1.49 A; A=64-354.
DR   PDB; 1ZJ0; X-ray; 1.67 A; A=64-354.
DR   PDB; 1ZJ1; X-ray; 1.65 A; A=64-354.
DR   PDB; 1ZJ2; X-ray; 1.69 A; A=64-354.
DR   PDB; 1ZJ3; X-ray; 1.69 A; A=64-354.
DR   PDB; 1ZJO; X-ray; 1.64 A; A=64-354.
DR   PDB; 1ZJP; X-ray; 1.59 A; A=64-354.
DR   PDB; 2A8U; X-ray; 1.69 A; A=64-354.
DR   PDB; 2A8W; X-ray; 1.59 A; A=64-354.
DR   PDB; 2I7B; X-ray; 1.99 A; A=64-354.
DR   PDB; 2O1F; X-ray; 1.99 A; A=64-354.
DR   PDB; 2O1G; X-ray; 1.71 A; A=64-354.
DR   PDB; 2O1H; X-ray; 1.67 A; A=64-354.
DR   PDB; 2PGV; X-ray; 1.79 A; A=64-354.
DR   PDB; 2PGY; X-ray; 2.39 A; A=64-354.
DR   PDB; 2RIT; X-ray; 1.43 A; A=64-354.
DR   PDB; 2RIX; X-ray; 1.75 A; A=64-354.
DR   PDB; 2RIY; X-ray; 1.55 A; A=64-354.
DR   PDB; 2RIZ; X-ray; 1.45 A; A=64-354.
DR   PDB; 2RJ0; X-ray; 1.52 A; A=64-354.
DR   PDB; 2RJ1; X-ray; 1.55 A; A=64-354.
DR   PDB; 2RJ4; X-ray; 1.47 A; A=64-354.
DR   PDB; 2RJ5; X-ray; 1.45 A; A=64-354.
DR   PDB; 2RJ6; X-ray; 1.41 A; A=64-354.
DR   PDB; 2RJ7; X-ray; 1.70 A; A=64-354.
DR   PDB; 2RJ8; X-ray; 1.69 A; A=64-354.
DR   PDB; 2RJ9; X-ray; 1.69 A; A=64-354.
DR   PDB; 2Y7A; X-ray; 2.06 A; A/B/C/D=64-354.
DR   PDB; 3I0C; X-ray; 1.55 A; A=69-354.
DR   PDB; 3I0D; X-ray; 1.90 A; A=69-354.
DR   PDB; 3I0E; X-ray; 1.81 A; A=69-354.
DR   PDB; 3I0F; X-ray; 1.56 A; A=69-354.
DR   PDB; 3I0G; X-ray; 1.40 A; A=69-354.
DR   PDB; 3I0H; X-ray; 2.00 A; A=69-354.
DR   PDB; 3I0I; X-ray; 1.90 A; X=69-354.
DR   PDB; 3I0J; X-ray; 1.48 A; A=69-354.
DR   PDB; 3I0K; X-ray; 2.20 A; A=69-354.
DR   PDB; 3I0L; X-ray; 1.60 A; A=69-354.
DR   PDB; 3IOH; X-ray; 1.25 A; A=64-354.
DR   PDB; 3IOI; X-ray; 1.45 A; A=64-354.
DR   PDB; 3IOJ; X-ray; 1.65 A; A/B=64-354.
DR   PDB; 3SX3; X-ray; 1.45 A; A=64-354.
DR   PDB; 3SX5; X-ray; 1.43 A; A=64-354.
DR   PDB; 3SX7; X-ray; 1.42 A; A=64-354.
DR   PDB; 3SX8; X-ray; 1.47 A; A=64-354.
DR   PDB; 3SXA; X-ray; 1.50 A; A=64-354.
DR   PDB; 3SXB; X-ray; 1.49 A; A=64-354.
DR   PDB; 3SXC; X-ray; 1.90 A; A=64-354.
DR   PDB; 3SXD; X-ray; 1.55 A; A=64-354.
DR   PDB; 3SXE; X-ray; 1.49 A; A=64-354.
DR   PDB; 3SXG; X-ray; 1.86 A; A=64-354.
DR   PDB; 3U0X; X-ray; 1.85 A; A/B=64-354.
DR   PDB; 3U0Y; X-ray; 1.60 A; A/B=64-354.
DR   PDB; 3V0L; X-ray; 1.75 A; A=64-354.
DR   PDB; 3V0M; X-ray; 1.68 A; A/B=64-354.
DR   PDB; 3V0N; X-ray; 1.75 A; A/B=64-354.
DR   PDB; 3V0O; X-ray; 1.65 A; A/B=64-354.
DR   PDB; 3V0P; X-ray; 1.90 A; A/B=64-354.
DR   PDB; 3V0Q; X-ray; 1.80 A; A/B=64-354.
DR   PDB; 3ZGF; X-ray; 1.70 A; A/B=64-354.
DR   PDB; 3ZGG; X-ray; 1.90 A; A=64-354.
DR   PDB; 4C2S; X-ray; 2.48 A; A/B=64-354.
DR   PDB; 4FQW; X-ray; 2.02 A; A=64-354.
DR   PDB; 4FRA; X-ray; 1.43 A; A=64-354.
DR   PDB; 4FRB; X-ray; 1.54 A; A=64-354.
DR   PDB; 4FRD; X-ray; 1.55 A; A=64-354.
DR   PDB; 4FRE; X-ray; 1.85 A; A=64-354.
DR   PDB; 4FRH; X-ray; 1.80 A; A=64-354.
DR   PDB; 4FRL; X-ray; 1.90 A; A=64-354.
DR   PDB; 4FRM; X-ray; 1.90 A; A=64-354.
DR   PDB; 4FRO; X-ray; 1.75 A; A=64-354.
DR   PDB; 4FRP; X-ray; 2.00 A; A=64-354.
DR   PDB; 4FRQ; X-ray; 2.35 A; A=64-354.
DR   PDB; 4GBP; X-ray; 2.15 A; A=64-354.
DR   PDB; 4KC1; X-ray; 1.50 A; A=64-346.
DR   PDB; 4KC2; X-ray; 1.70 A; A=64-346.
DR   PDB; 4KC4; X-ray; 1.60 A; A=64-346.
DR   PDB; 4KXO; X-ray; 2.00 A; A=64-354.
DR   PDB; 4Y62; X-ray; 1.60 A; A=1-354.
DR   PDB; 4Y63; X-ray; 1.30 A; A=1-354.
DR   PDB; 4Y64; X-ray; 1.60 A; A=1-354.
DR   PDB; 5BXC; X-ray; 1.40 A; A=64-354.
DR   PDB; 5C1G; X-ray; 1.46 A; A=64-354.
DR   PDB; 5C1H; X-ray; 1.55 A; A=64-354.
DR   PDB; 5C1L; X-ray; 1.40 A; A=64-354.
DR   PDB; 5C36; X-ray; 1.55 A; A=64-354.
DR   PDB; 5C38; X-ray; 1.45 A; A=64-354.
DR   PDB; 5C3A; X-ray; 1.33 A; A=64-354.
DR   PDB; 5C3B; X-ray; 1.40 A; A=64-354.
DR   PDB; 5C3D; X-ray; 1.39 A; A=64-354.
DR   PDB; 5C47; X-ray; 1.39 A; A=64-354.
DR   PDB; 5C48; X-ray; 1.46 A; A=64-354.
DR   PDB; 5C49; X-ray; 1.49 A; A=64-354.
DR   PDB; 5C4B; X-ray; 1.54 A; A=64-354.
DR   PDB; 5C4C; X-ray; 1.43 A; A=64-354.
DR   PDB; 5C4D; X-ray; 1.40 A; A=64-354.
DR   PDB; 5C4E; X-ray; 1.55 A; A=64-354.
DR   PDB; 5C4F; X-ray; 1.41 A; A=64-354.
DR   PDB; 5C8R; X-ray; 1.45 A; A=64-354.
DR   PDB; 5CMF; X-ray; 1.95 A; X=64-345.
DR   PDB; 5CMG; X-ray; 1.83 A; X=64-354.
DR   PDB; 5CMH; X-ray; 1.61 A; A=64-354.
DR   PDB; 5CMI; X-ray; 1.85 A; A=64-354.
DR   PDB; 5CMJ; X-ray; 1.73 A; A=64-354.
DR   PDB; 5CQL; X-ray; 1.69 A; X=64-354.
DR   PDB; 5CQM; X-ray; 1.65 A; X=64-354.
DR   PDB; 5CQN; X-ray; 1.61 A; X=64-354.
DR   PDB; 5CQO; X-ray; 1.69 A; A=64-354.
DR   PDB; 5CQP; X-ray; 1.83 A; A=64-354.
DR   PDB; 5M79; X-ray; 1.30 A; A=64-354.
DR   PDB; 5M7A; X-ray; 1.30 A; A=64-354.
DR   PDB; 5M7B; X-ray; 1.50 A; A=64-354.
DR   PDB; 5M7C; X-ray; 1.60 A; A/B=64-354.
DR   PDB; 5M7D; X-ray; 1.20 A; A=64-354.
DR   PDB; 5TJK; X-ray; 1.45 A; A=64-354.
DR   PDB; 5TJL; X-ray; 1.89 A; A=64-354.
DR   PDB; 5TJN; X-ray; 1.47 A; A=64-354.
DR   PDB; 5TJO; X-ray; 1.57 A; A=64-354.
DR   PDB; 6BJI; X-ray; 1.54 A; A=64-354.
DR   PDB; 6BJJ; X-ray; 1.45 A; A=64-354.
DR   PDB; 6BJK; X-ray; 2.12 A; A=64-354.
DR   PDB; 6BJL; X-ray; 1.69 A; A=64-345.
DR   PDB; 6BJM; X-ray; 1.45 A; A=64-345.
DR   PDB; 6GWY; X-ray; 1.40 A; A=64-354.
DR   PDB; 6GWZ; X-ray; 1.65 A; A=64-354.
DR   PDB; 6GX0; X-ray; 1.25 A; A=64-354.
DR   PDB; 6GX1; X-ray; 1.60 A; A=64-354.
DR   PDB; 6GX2; X-ray; 1.07 A; A=64-354.
DR   PDBsum; 1LZ0; -.
DR   PDBsum; 1LZ7; -.
DR   PDBsum; 1LZI; -.
DR   PDBsum; 1LZJ; -.
DR   PDBsum; 1R7T; -.
DR   PDBsum; 1R7U; -.
DR   PDBsum; 1R7V; -.
DR   PDBsum; 1R7X; -.
DR   PDBsum; 1R7Y; -.
DR   PDBsum; 1R80; -.
DR   PDBsum; 1R81; -.
DR   PDBsum; 1R82; -.
DR   PDBsum; 1WSZ; -.
DR   PDBsum; 1WT0; -.
DR   PDBsum; 1WT1; -.
DR   PDBsum; 1WT2; -.
DR   PDBsum; 1WT3; -.
DR   PDBsum; 1XZ6; -.
DR   PDBsum; 1ZHJ; -.
DR   PDBsum; 1ZI1; -.
DR   PDBsum; 1ZI3; -.
DR   PDBsum; 1ZI4; -.
DR   PDBsum; 1ZI5; -.
DR   PDBsum; 1ZIZ; -.
DR   PDBsum; 1ZJ0; -.
DR   PDBsum; 1ZJ1; -.
DR   PDBsum; 1ZJ2; -.
DR   PDBsum; 1ZJ3; -.
DR   PDBsum; 1ZJO; -.
DR   PDBsum; 1ZJP; -.
DR   PDBsum; 2A8U; -.
DR   PDBsum; 2A8W; -.
DR   PDBsum; 2I7B; -.
DR   PDBsum; 2O1F; -.
DR   PDBsum; 2O1G; -.
DR   PDBsum; 2O1H; -.
DR   PDBsum; 2PGV; -.
DR   PDBsum; 2PGY; -.
DR   PDBsum; 2RIT; -.
DR   PDBsum; 2RIX; -.
DR   PDBsum; 2RIY; -.
DR   PDBsum; 2RIZ; -.
DR   PDBsum; 2RJ0; -.
DR   PDBsum; 2RJ1; -.
DR   PDBsum; 2RJ4; -.
DR   PDBsum; 2RJ5; -.
DR   PDBsum; 2RJ6; -.
DR   PDBsum; 2RJ7; -.
DR   PDBsum; 2RJ8; -.
DR   PDBsum; 2RJ9; -.
DR   PDBsum; 2Y7A; -.
DR   PDBsum; 3I0C; -.
DR   PDBsum; 3I0D; -.
DR   PDBsum; 3I0E; -.
DR   PDBsum; 3I0F; -.
DR   PDBsum; 3I0G; -.
DR   PDBsum; 3I0H; -.
DR   PDBsum; 3I0I; -.
DR   PDBsum; 3I0J; -.
DR   PDBsum; 3I0K; -.
DR   PDBsum; 3I0L; -.
DR   PDBsum; 3IOH; -.
DR   PDBsum; 3IOI; -.
DR   PDBsum; 3IOJ; -.
DR   PDBsum; 3SX3; -.
DR   PDBsum; 3SX5; -.
DR   PDBsum; 3SX7; -.
DR   PDBsum; 3SX8; -.
DR   PDBsum; 3SXA; -.
DR   PDBsum; 3SXB; -.
DR   PDBsum; 3SXC; -.
DR   PDBsum; 3SXD; -.
DR   PDBsum; 3SXE; -.
DR   PDBsum; 3SXG; -.
DR   PDBsum; 3U0X; -.
DR   PDBsum; 3U0Y; -.
DR   PDBsum; 3V0L; -.
DR   PDBsum; 3V0M; -.
DR   PDBsum; 3V0N; -.
DR   PDBsum; 3V0O; -.
DR   PDBsum; 3V0P; -.
DR   PDBsum; 3V0Q; -.
DR   PDBsum; 3ZGF; -.
DR   PDBsum; 3ZGG; -.
DR   PDBsum; 4C2S; -.
DR   PDBsum; 4FQW; -.
DR   PDBsum; 4FRA; -.
DR   PDBsum; 4FRB; -.
DR   PDBsum; 4FRD; -.
DR   PDBsum; 4FRE; -.
DR   PDBsum; 4FRH; -.
DR   PDBsum; 4FRL; -.
DR   PDBsum; 4FRM; -.
DR   PDBsum; 4FRO; -.
DR   PDBsum; 4FRP; -.
DR   PDBsum; 4FRQ; -.
DR   PDBsum; 4GBP; -.
DR   PDBsum; 4KC1; -.
DR   PDBsum; 4KC2; -.
DR   PDBsum; 4KC4; -.
DR   PDBsum; 4KXO; -.
DR   PDBsum; 4Y62; -.
DR   PDBsum; 4Y63; -.
DR   PDBsum; 4Y64; -.
DR   PDBsum; 5BXC; -.
DR   PDBsum; 5C1G; -.
DR   PDBsum; 5C1H; -.
DR   PDBsum; 5C1L; -.
DR   PDBsum; 5C36; -.
DR   PDBsum; 5C38; -.
DR   PDBsum; 5C3A; -.
DR   PDBsum; 5C3B; -.
DR   PDBsum; 5C3D; -.
DR   PDBsum; 5C47; -.
DR   PDBsum; 5C48; -.
DR   PDBsum; 5C49; -.
DR   PDBsum; 5C4B; -.
DR   PDBsum; 5C4C; -.
DR   PDBsum; 5C4D; -.
DR   PDBsum; 5C4E; -.
DR   PDBsum; 5C4F; -.
DR   PDBsum; 5C8R; -.
DR   PDBsum; 5CMF; -.
DR   PDBsum; 5CMG; -.
DR   PDBsum; 5CMH; -.
DR   PDBsum; 5CMI; -.
DR   PDBsum; 5CMJ; -.
DR   PDBsum; 5CQL; -.
DR   PDBsum; 5CQM; -.
DR   PDBsum; 5CQN; -.
DR   PDBsum; 5CQO; -.
DR   PDBsum; 5CQP; -.
DR   PDBsum; 5M79; -.
DR   PDBsum; 5M7A; -.
DR   PDBsum; 5M7B; -.
DR   PDBsum; 5M7C; -.
DR   PDBsum; 5M7D; -.
DR   PDBsum; 5TJK; -.
DR   PDBsum; 5TJL; -.
DR   PDBsum; 5TJN; -.
DR   PDBsum; 5TJO; -.
DR   PDBsum; 6BJI; -.
DR   PDBsum; 6BJJ; -.
DR   PDBsum; 6BJK; -.
DR   PDBsum; 6BJL; -.
DR   PDBsum; 6BJM; -.
DR   PDBsum; 6GWY; -.
DR   PDBsum; 6GWZ; -.
DR   PDBsum; 6GX0; -.
DR   PDBsum; 6GX1; -.
DR   PDBsum; 6GX2; -.
DR   AlphaFoldDB; P16442; -.
DR   SMR; P16442; -.
DR   BioGRID; 106546; 5.
DR   STRING; 9606.ENSP00000483018; -.
DR   BindingDB; P16442; -.
DR   ChEMBL; CHEMBL2321639; -.
DR   DrugBank; DB04141; 2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol.
DR   DrugBank; DB03772; 2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,5-Diol.
DR   DrugBank; DB07357; 4-AMINO-2-HEXYLOXY-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-3,5-DIOL.
DR   DrugBank; DB07378; 4-AMINO-2-OCTYLOXY-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-3,5-DIOL.
DR   DrugBank; DB04681; BETA-METHYLLACTOSIDE.
DR   DrugBank; DB04680; GALACTOSE GREASE.
DR   DrugBank; DB03501; Galactose-uridine-5'-diphosphate.
DR   DrugBank; DB04678; H TYPE II TRISACCHARIDE.
DR   DrugBank; DB04679; Human blood group H type 1 trisaccharide.
DR   DrugBank; DB07341; octyl 3-amino-3-deoxy-2-O-(2,6-dideoxy-alpha-L-lyxo-hexopyranosyl)-beta-D-galactopyranoside.
DR   DrugBank; DB07633; octyl 3-deoxy-2-O-(6-deoxy-alpha-L-galactopyranosyl)-beta-D-xylo-hexopyranoside.
DR   DrugBank; DB03435; Uridine-5'-Diphosphate.
DR   DrugBank; DB02196; Uridine-Diphosphate-N-Acetylgalactosamine.
DR   CAZy; GT6; Glycosyltransferase Family 6.
DR   GlyGen; P16442; 1 site.
DR   iPTMnet; P16442; -.
DR   PhosphoSitePlus; P16442; -.
DR   BioMuta; ABO; -.
DR   DMDM; 114949; -.
DR   jPOST; P16442; -.
DR   MassIVE; P16442; -.
DR   PeptideAtlas; P16442; -.
DR   PRIDE; P16442; -.
DR   ProteomicsDB; 53361; -.
DR   DNASU; 28; -.
DR   GeneID; 28; -.
DR   KEGG; hsa:28; -.
DR   CTD; 28; -.
DR   DisGeNET; 28; -.
DR   GeneCards; ABO; -.
DR   HGNC; HGNC:79; ABO.
DR   MIM; 110300; gene.
DR   MIM; 616093; phenotype.
DR   neXtProt; NX_P16442; -.
DR   PharmGKB; PA24415; -.
DR   eggNOG; ENOG502QQAJ; Eukaryota.
DR   InParanoid; P16442; -.
DR   OrthoDB; 1204439at2759; -.
DR   PhylomeDB; P16442; -.
DR   BioCyc; MetaCyc:HS10887-MON; -.
DR   BRENDA; 2.4.1.37; 2681.
DR   BRENDA; 2.4.1.40; 2681.
DR   BRENDA; 2.4.1.88; 2681.
DR   PathwayCommons; P16442; -.
DR   Reactome; R-HSA-9033807; ABO blood group biosynthesis.
DR   UniPathway; UPA00378; -.
DR   BioGRID-ORCS; 28; 12 hits in 207 CRISPR screens.
DR   ChiTaRS; ABO; human.
DR   EvolutionaryTrace; P16442; -.
DR   GeneWiki; ABO_(gene); -.
DR   GenomeRNAi; 28; -.
DR   Pharos; P16442; Tbio.
DR   PRO; PR:P16442; -.
DR   Proteomes; UP000005640; Unplaced.
DR   RNAct; P16442; protein.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005794; C:Golgi apparatus; IBA:GO_Central.
DR   GO; GO:0032580; C:Golgi cisterna membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0031982; C:vesicle; IBA:GO_Central.
DR   GO; GO:0003823; F:antigen binding; IMP:CAFA.
DR   GO; GO:0004381; F:fucosylgalactoside 3-alpha-galactosyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004380; F:glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0030145; F:manganese ion binding; IMP:CAFA.
DR   GO; GO:0000166; F:nucleotide binding; IMP:CAFA.
DR   GO; GO:0005975; P:carbohydrate metabolic process; IEA:InterPro.
DR   GO; GO:0030259; P:lipid glycosylation; IBA:GO_Central.
DR   GO; GO:0006486; P:protein glycosylation; IEA:UniProtKB-UniPathway.
DR   DisProt; DP00339; -.
DR   Gene3D; 3.90.550.10; -; 1.
DR   InterPro; IPR005076; Glyco_trans_6.
DR   InterPro; IPR029044; Nucleotide-diphossugar_trans.
DR   PANTHER; PTHR10462; PTHR10462; 1.
DR   Pfam; PF03414; Glyco_transf_6; 1.
DR   SUPFAM; SSF53448; SSF53448; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Blood group antigen; Direct protein sequencing; Glycoprotein;
KW   Glycosyltransferase; Golgi apparatus; Manganese; Membrane; Metal-binding;
KW   Reference proteome; Secreted; Signal-anchor; Transferase; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..354
FT                   /note="Histo-blood group ABO system transferase"
FT                   /id="PRO_0000012268"
FT   CHAIN           54..354
FT                   /note="Fucosylglycoprotein alpha-N-
FT                   acetylgalactosaminyltransferase soluble form"
FT                   /id="PRO_0000012269"
FT   TOPO_DOM        1..32
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        33..53
FT                   /note="Helical; Signal-anchor for type II membrane protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        54..354
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   ACT_SITE        303
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000250|UniProtKB:P14769"
FT   BINDING         121..123
FT                   /ligand="UDP-N-acetyl-alpha-D-galactosamine"
FT                   /ligand_id="ChEBI:CHEBI:67138"
FT                   /evidence="ECO:0000269|PubMed:12198488,
FT                   ECO:0000269|PubMed:12972418, ECO:0000269|PubMed:15475562,
FT                   ECO:0000269|PubMed:16326711, ECO:0000269|PubMed:17259183,
FT                   ECO:0007744|PDB:1LZI, ECO:0007744|PDB:1LZJ,
FT                   ECO:0007744|PDB:1R7Y, ECO:0007744|PDB:1R80,
FT                   ECO:0007744|PDB:1R81, ECO:0007744|PDB:1R82,
FT                   ECO:0007744|PDB:1WT3, ECO:0007744|PDB:1ZI5,
FT                   ECO:0007744|PDB:1ZJ2, ECO:0007744|PDB:1ZJO,
FT                   ECO:0007744|PDB:1ZJP, ECO:0007744|PDB:2A8U,
FT                   ECO:0007744|PDB:2A8W, ECO:0007744|PDB:2O1H,
FT                   ECO:0007744|PDB:2RIX, ECO:0007744|PDB:2RJ0,
FT                   ECO:0007744|PDB:2RJ1, ECO:0007744|PDB:2RJ4,
FT                   ECO:0007744|PDB:2RJ5, ECO:0007744|PDB:2RJ7,
FT                   ECO:0007744|PDB:2RJ8, ECO:0007744|PDB:2RJ9,
FT                   ECO:0007744|PDB:2Y7A, ECO:0007744|PDB:3I0D,
FT                   ECO:0007744|PDB:3I0F, ECO:0007744|PDB:3I0G,
FT                   ECO:0007744|PDB:3I0I, ECO:0007744|PDB:3I0K,
FT                   ECO:0007744|PDB:3I0L, ECO:0007744|PDB:3IOI,
FT                   ECO:0007744|PDB:3IOJ, ECO:0007744|PDB:3SX3,
FT                   ECO:0007744|PDB:3SX5, ECO:0007744|PDB:3SX7,
FT                   ECO:0007744|PDB:3SX8, ECO:0007744|PDB:3SXA,
FT                   ECO:0007744|PDB:3SXB, ECO:0007744|PDB:3SXC,
FT                   ECO:0007744|PDB:3SXD, ECO:0007744|PDB:3SXE,
FT                   ECO:0007744|PDB:3SXG, ECO:0007744|PDB:3U0Y,
FT                   ECO:0007744|PDB:3V0L, ECO:0007744|PDB:3V0N,
FT                   ECO:0007744|PDB:3V0Q, ECO:0007744|PDB:3ZGF,
FT                   ECO:0007744|PDB:3ZGG, ECO:0007744|PDB:4C2S,
FT                   ECO:0007744|PDB:4FQW, ECO:0007744|PDB:4FRA,
FT                   ECO:0007744|PDB:4FRB, ECO:0007744|PDB:4FRD,
FT                   ECO:0007744|PDB:4FRE, ECO:0007744|PDB:4FRH,
FT                   ECO:0007744|PDB:4FRL, ECO:0007744|PDB:4FRM,
FT                   ECO:0007744|PDB:4FRO, ECO:0007744|PDB:4FRP,
FT                   ECO:0007744|PDB:4FRQ, ECO:0007744|PDB:4GBP,
FT                   ECO:0007744|PDB:4KC1, ECO:0007744|PDB:4KC2,
FT                   ECO:0007744|PDB:4KC4"
FT   BINDING         126
FT                   /ligand="UDP-N-acetyl-alpha-D-galactosamine"
FT                   /ligand_id="ChEBI:CHEBI:67138"
FT                   /evidence="ECO:0000269|PubMed:12198488,
FT                   ECO:0000269|PubMed:12972418, ECO:0000269|PubMed:15475562,
FT                   ECO:0000269|PubMed:16326711, ECO:0000269|PubMed:17259183,
FT                   ECO:0007744|PDB:1LZI, ECO:0007744|PDB:1LZJ,
FT                   ECO:0007744|PDB:1R7Y, ECO:0007744|PDB:1R80,
FT                   ECO:0007744|PDB:1R81, ECO:0007744|PDB:1R82,
FT                   ECO:0007744|PDB:1WT1, ECO:0007744|PDB:1WT2,
FT                   ECO:0007744|PDB:1WT3, ECO:0007744|PDB:1ZI5,
FT                   ECO:0007744|PDB:1ZJ2, ECO:0007744|PDB:1ZJO,
FT                   ECO:0007744|PDB:1ZJP, ECO:0007744|PDB:2A8U,
FT                   ECO:0007744|PDB:2A8W, ECO:0007744|PDB:2O1H,
FT                   ECO:0007744|PDB:2RIX, ECO:0007744|PDB:2RJ0,
FT                   ECO:0007744|PDB:2RJ1, ECO:0007744|PDB:2RJ4,
FT                   ECO:0007744|PDB:2RJ5, ECO:0007744|PDB:2RJ7,
FT                   ECO:0007744|PDB:2RJ8, ECO:0007744|PDB:2RJ9,
FT                   ECO:0007744|PDB:2Y7A, ECO:0007744|PDB:3I0D,
FT                   ECO:0007744|PDB:3I0F, ECO:0007744|PDB:3I0G,
FT                   ECO:0007744|PDB:3I0I, ECO:0007744|PDB:3I0K,
FT                   ECO:0007744|PDB:3I0L, ECO:0007744|PDB:3IOI,
FT                   ECO:0007744|PDB:3IOJ, ECO:0007744|PDB:3SX3,
FT                   ECO:0007744|PDB:3SX5, ECO:0007744|PDB:3SX7,
FT                   ECO:0007744|PDB:3SX8, ECO:0007744|PDB:3SXA,
FT                   ECO:0007744|PDB:3SXB, ECO:0007744|PDB:3SXC,
FT                   ECO:0007744|PDB:3SXD, ECO:0007744|PDB:3SXE,
FT                   ECO:0007744|PDB:3SXG, ECO:0007744|PDB:3U0Y,
FT                   ECO:0007744|PDB:3V0L, ECO:0007744|PDB:3V0N,
FT                   ECO:0007744|PDB:3V0Q, ECO:0007744|PDB:3ZGF,
FT                   ECO:0007744|PDB:3ZGG, ECO:0007744|PDB:4C2S,
FT                   ECO:0007744|PDB:4FQW, ECO:0007744|PDB:4FRA,
FT                   ECO:0007744|PDB:4FRB, ECO:0007744|PDB:4FRD,
FT                   ECO:0007744|PDB:4FRE, ECO:0007744|PDB:4FRH,
FT                   ECO:0007744|PDB:4FRL, ECO:0007744|PDB:4FRM,
FT                   ECO:0007744|PDB:4FRO, ECO:0007744|PDB:4FRP,
FT                   ECO:0007744|PDB:4FRQ, ECO:0007744|PDB:4GBP,
FT                   ECO:0007744|PDB:4KC1, ECO:0007744|PDB:4KC2,
FT                   ECO:0007744|PDB:4KC4"
FT   BINDING         211..213
FT                   /ligand="UDP-N-acetyl-alpha-D-galactosamine"
FT                   /ligand_id="ChEBI:CHEBI:67138"
FT                   /evidence="ECO:0000269|PubMed:12198488,
FT                   ECO:0000269|PubMed:12972418, ECO:0000269|PubMed:15475562,
FT                   ECO:0000269|PubMed:16326711, ECO:0000269|PubMed:17259183,
FT                   ECO:0007744|PDB:1LZI, ECO:0007744|PDB:1LZJ,
FT                   ECO:0007744|PDB:1R7Y, ECO:0007744|PDB:1R80,
FT                   ECO:0007744|PDB:1R81, ECO:0007744|PDB:1R82,
FT                   ECO:0007744|PDB:1WT1, ECO:0007744|PDB:1WT2,
FT                   ECO:0007744|PDB:1WT3, ECO:0007744|PDB:1ZI5,
FT                   ECO:0007744|PDB:1ZJ2, ECO:0007744|PDB:1ZJO,
FT                   ECO:0007744|PDB:1ZJP, ECO:0007744|PDB:2A8U,
FT                   ECO:0007744|PDB:2A8W, ECO:0007744|PDB:2O1H,
FT                   ECO:0007744|PDB:2RIX, ECO:0007744|PDB:2RJ0,
FT                   ECO:0007744|PDB:2RJ1, ECO:0007744|PDB:2RJ4,
FT                   ECO:0007744|PDB:2RJ5, ECO:0007744|PDB:2RJ7,
FT                   ECO:0007744|PDB:2RJ8, ECO:0007744|PDB:2RJ9,
FT                   ECO:0007744|PDB:2Y7A, ECO:0007744|PDB:3I0D,
FT                   ECO:0007744|PDB:3I0F, ECO:0007744|PDB:3I0G,
FT                   ECO:0007744|PDB:3I0I, ECO:0007744|PDB:3I0K,
FT                   ECO:0007744|PDB:3I0L, ECO:0007744|PDB:3IOI,
FT                   ECO:0007744|PDB:3IOJ, ECO:0007744|PDB:3SX3,
FT                   ECO:0007744|PDB:3SX5, ECO:0007744|PDB:3SX7,
FT                   ECO:0007744|PDB:3SX8, ECO:0007744|PDB:3SXA,
FT                   ECO:0007744|PDB:3SXB, ECO:0007744|PDB:3SXC,
FT                   ECO:0007744|PDB:3SXD, ECO:0007744|PDB:3SXE,
FT                   ECO:0007744|PDB:3SXG, ECO:0007744|PDB:3U0Y,
FT                   ECO:0007744|PDB:3V0L, ECO:0007744|PDB:3V0N,
FT                   ECO:0007744|PDB:3V0Q, ECO:0007744|PDB:3ZGF,
FT                   ECO:0007744|PDB:3ZGG, ECO:0007744|PDB:4C2S,
FT                   ECO:0007744|PDB:4FQW, ECO:0007744|PDB:4FRA,
FT                   ECO:0007744|PDB:4FRB, ECO:0007744|PDB:4FRD,
FT                   ECO:0007744|PDB:4FRE, ECO:0007744|PDB:4FRH,
FT                   ECO:0007744|PDB:4FRL, ECO:0007744|PDB:4FRM,
FT                   ECO:0007744|PDB:4FRO, ECO:0007744|PDB:4FRP,
FT                   ECO:0007744|PDB:4FRQ, ECO:0007744|PDB:4GBP,
FT                   ECO:0007744|PDB:4KC1, ECO:0007744|PDB:4KC2,
FT                   ECO:0007744|PDB:4KC4"
FT   BINDING         211
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /evidence="ECO:0000269|PubMed:12198488,
FT                   ECO:0000269|PubMed:12972418, ECO:0000269|PubMed:16326711,
FT                   ECO:0000269|PubMed:17259183, ECO:0007744|PDB:1LZJ,
FT                   ECO:0007744|PDB:1R80, ECO:0007744|PDB:1ZJ2,
FT                   ECO:0007744|PDB:1ZJP, ECO:0007744|PDB:2A8U,
FT                   ECO:0007744|PDB:2O1H, ECO:0007744|PDB:2RIX,
FT                   ECO:0007744|PDB:2RJ0, ECO:0007744|PDB:2RJ1,
FT                   ECO:0007744|PDB:2RJ4, ECO:0007744|PDB:2RJ5,
FT                   ECO:0007744|PDB:2RJ7, ECO:0007744|PDB:2RJ8,
FT                   ECO:0007744|PDB:2RJ9, ECO:0007744|PDB:3I0F,
FT                   ECO:0007744|PDB:3IOI, ECO:0007744|PDB:3IOJ,
FT                   ECO:0007744|PDB:3SX3, ECO:0007744|PDB:3SX5,
FT                   ECO:0007744|PDB:3SX7, ECO:0007744|PDB:3SXA,
FT                   ECO:0007744|PDB:3SXB, ECO:0007744|PDB:3SXD,
FT                   ECO:0007744|PDB:3SXE, ECO:0007744|PDB:3SXG,
FT                   ECO:0007744|PDB:3U0Y, ECO:0007744|PDB:3V0L,
FT                   ECO:0007744|PDB:3V0M, ECO:0007744|PDB:3V0N,
FT                   ECO:0007744|PDB:3V0O, ECO:0007744|PDB:3V0P,
FT                   ECO:0007744|PDB:3V0Q, ECO:0007744|PDB:3ZGF,
FT                   ECO:0007744|PDB:3ZGG, ECO:0007744|PDB:4C2S,
FT                   ECO:0007744|PDB:4FRB, ECO:0007744|PDB:4FRD,
FT                   ECO:0007744|PDB:4FRH, ECO:0007744|PDB:4FRL,
FT                   ECO:0007744|PDB:4FRO, ECO:0007744|PDB:4FRP,
FT                   ECO:0007744|PDB:4FRQ, ECO:0007744|PDB:4GBP"
FT   BINDING         213
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /evidence="ECO:0000269|PubMed:12198488,
FT                   ECO:0000269|PubMed:12972418, ECO:0000269|PubMed:16326711,
FT                   ECO:0000269|PubMed:17259183, ECO:0007744|PDB:1LZJ,
FT                   ECO:0007744|PDB:1R80, ECO:0007744|PDB:1ZJ2,
FT                   ECO:0007744|PDB:1ZJP, ECO:0007744|PDB:2A8U,
FT                   ECO:0007744|PDB:2O1H, ECO:0007744|PDB:2RIX,
FT                   ECO:0007744|PDB:2RJ0, ECO:0007744|PDB:2RJ1,
FT                   ECO:0007744|PDB:2RJ4, ECO:0007744|PDB:2RJ5,
FT                   ECO:0007744|PDB:2RJ7, ECO:0007744|PDB:2RJ8,
FT                   ECO:0007744|PDB:2RJ9, ECO:0007744|PDB:3I0F,
FT                   ECO:0007744|PDB:3IOI, ECO:0007744|PDB:3IOJ,
FT                   ECO:0007744|PDB:3SX3, ECO:0007744|PDB:3SX5,
FT                   ECO:0007744|PDB:3SX7, ECO:0007744|PDB:3SXA,
FT                   ECO:0007744|PDB:3SXB, ECO:0007744|PDB:3SXD,
FT                   ECO:0007744|PDB:3SXE, ECO:0007744|PDB:3SXG,
FT                   ECO:0007744|PDB:3U0Y, ECO:0007744|PDB:3V0L,
FT                   ECO:0007744|PDB:3V0M, ECO:0007744|PDB:3V0N,
FT                   ECO:0007744|PDB:3V0O, ECO:0007744|PDB:3V0P,
FT                   ECO:0007744|PDB:3V0Q, ECO:0007744|PDB:3ZGF,
FT                   ECO:0007744|PDB:3ZGG, ECO:0007744|PDB:4C2S,
FT                   ECO:0007744|PDB:4FRB, ECO:0007744|PDB:4FRD,
FT                   ECO:0007744|PDB:4FRH, ECO:0007744|PDB:4FRL,
FT                   ECO:0007744|PDB:4FRO, ECO:0007744|PDB:4FRP,
FT                   ECO:0007744|PDB:4FRQ, ECO:0007744|PDB:4GBP"
FT   BINDING         233
FT                   /ligand="an alpha-L-fucosyl-(1->2)-beta-D-galactosyl
FT                   derivative"
FT                   /ligand_id="ChEBI:CHEBI:140327"
FT                   /evidence="ECO:0000269|PubMed:16326711,
FT                   ECO:0007744|PDB:1ZHJ, ECO:0007744|PDB:1ZI3,
FT                   ECO:0007744|PDB:1ZI4, ECO:0007744|PDB:1ZI5,
FT                   ECO:0007744|PDB:1ZJ1, ECO:0007744|PDB:1ZJ2,
FT                   ECO:0007744|PDB:1ZJ3, ECO:0007744|PDB:2A8U,
FT                   ECO:0007744|PDB:2RJ1, ECO:0007744|PDB:2RJ4,
FT                   ECO:0007744|PDB:2RJ7, ECO:0007744|PDB:2RJ8,
FT                   ECO:0007744|PDB:2RJ9, ECO:0007744|PDB:3SX3,
FT                   ECO:0007744|PDB:3SX7, ECO:0007744|PDB:3SX8,
FT                   ECO:0007744|PDB:3SXA, ECO:0007744|PDB:3SXG,
FT                   ECO:0007744|PDB:3V0M, ECO:0007744|PDB:3V0N,
FT                   ECO:0007744|PDB:3V0O, ECO:0007744|PDB:3V0P,
FT                   ECO:0007744|PDB:3V0Q, ECO:0007744|PDB:3ZGF,
FT                   ECO:0007744|PDB:4C2S, ECO:0007744|PDB:4FQW,
FT                   ECO:0007744|PDB:4FRA, ECO:0007744|PDB:4FRB,
FT                   ECO:0007744|PDB:4FRD, ECO:0007744|PDB:4FRE,
FT                   ECO:0007744|PDB:4FRH, ECO:0007744|PDB:4FRL,
FT                   ECO:0007744|PDB:4FRM, ECO:0007744|PDB:4FRO,
FT                   ECO:0007744|PDB:4FRP, ECO:0007744|PDB:4FRQ,
FT                   ECO:0007744|PDB:4GBP, ECO:0007744|PDB:4KC1,
FT                   ECO:0007744|PDB:4KC2, ECO:0007744|PDB:4KC4"
FT   BINDING         245
FT                   /ligand="an alpha-L-fucosyl-(1->2)-beta-D-galactosyl
FT                   derivative"
FT                   /ligand_id="ChEBI:CHEBI:140327"
FT                   /evidence="ECO:0000269|PubMed:12972418,
FT                   ECO:0000269|PubMed:15475562, ECO:0000269|PubMed:16326711,
FT                   ECO:0007744|PDB:1R7T, ECO:0007744|PDB:1R7U,
FT                   ECO:0007744|PDB:1WT2, ECO:0007744|PDB:1ZHJ,
FT                   ECO:0007744|PDB:1ZI3, ECO:0007744|PDB:1ZI4,
FT                   ECO:0007744|PDB:1ZI5, ECO:0007744|PDB:1ZIZ,
FT                   ECO:0007744|PDB:1ZJ0, ECO:0007744|PDB:1ZJ1,
FT                   ECO:0007744|PDB:1ZJ2, ECO:0007744|PDB:1ZJ3,
FT                   ECO:0007744|PDB:2A8U, ECO:0007744|PDB:2RIY,
FT                   ECO:0007744|PDB:2RJ1, ECO:0007744|PDB:2RJ4,
FT                   ECO:0007744|PDB:2RJ6, ECO:0007744|PDB:2RJ7,
FT                   ECO:0007744|PDB:2RJ8, ECO:0007744|PDB:2RJ9,
FT                   ECO:0007744|PDB:3SX3, ECO:0007744|PDB:3SX5,
FT                   ECO:0007744|PDB:3SX7, ECO:0007744|PDB:3SX8,
FT                   ECO:0007744|PDB:3SXA, ECO:0007744|PDB:3SXB,
FT                   ECO:0007744|PDB:3SXC, ECO:0007744|PDB:3SXD,
FT                   ECO:0007744|PDB:3SXE, ECO:0007744|PDB:3SXG,
FT                   ECO:0007744|PDB:3V0M, ECO:0007744|PDB:3V0O,
FT                   ECO:0007744|PDB:3V0P, ECO:0007744|PDB:3V0Q,
FT                   ECO:0007744|PDB:4C2S, ECO:0007744|PDB:4FQW,
FT                   ECO:0007744|PDB:4FRA, ECO:0007744|PDB:4FRB,
FT                   ECO:0007744|PDB:4FRD, ECO:0007744|PDB:4FRE,
FT                   ECO:0007744|PDB:4FRH, ECO:0007744|PDB:4FRL,
FT                   ECO:0007744|PDB:4FRM, ECO:0007744|PDB:4FRO,
FT                   ECO:0007744|PDB:4FRP, ECO:0007744|PDB:4FRQ,
FT                   ECO:0007744|PDB:4GBP, ECO:0007744|PDB:4KC1,
FT                   ECO:0007744|PDB:4KC2, ECO:0007744|PDB:4KC4"
FT   BINDING         303
FT                   /ligand="an alpha-L-fucosyl-(1->2)-beta-D-galactosyl
FT                   derivative"
FT                   /ligand_id="ChEBI:CHEBI:140327"
FT                   /evidence="ECO:0000269|PubMed:12972418,
FT                   ECO:0000269|PubMed:15475562, ECO:0000269|PubMed:16326711,
FT                   ECO:0007744|PDB:1R7T, ECO:0007744|PDB:1R7U,
FT                   ECO:0007744|PDB:1WT2, ECO:0007744|PDB:1ZHJ,
FT                   ECO:0007744|PDB:1ZI3, ECO:0007744|PDB:1ZI4,
FT                   ECO:0007744|PDB:1ZI5, ECO:0007744|PDB:1ZIZ,
FT                   ECO:0007744|PDB:1ZJ0, ECO:0007744|PDB:1ZJ1,
FT                   ECO:0007744|PDB:1ZJ2, ECO:0007744|PDB:1ZJ3,
FT                   ECO:0007744|PDB:2A8U, ECO:0007744|PDB:2RIY,
FT                   ECO:0007744|PDB:2RJ1, ECO:0007744|PDB:2RJ4,
FT                   ECO:0007744|PDB:2RJ6, ECO:0007744|PDB:2RJ7,
FT                   ECO:0007744|PDB:2RJ8, ECO:0007744|PDB:2RJ9,
FT                   ECO:0007744|PDB:3I0G, ECO:0007744|PDB:3I0L,
FT                   ECO:0007744|PDB:3IOI, ECO:0007744|PDB:3SX3,
FT                   ECO:0007744|PDB:3SX5, ECO:0007744|PDB:3SX7,
FT                   ECO:0007744|PDB:3SX8, ECO:0007744|PDB:3SXA,
FT                   ECO:0007744|PDB:3SXB, ECO:0007744|PDB:3SXC,
FT                   ECO:0007744|PDB:3SXD, ECO:0007744|PDB:3SXE,
FT                   ECO:0007744|PDB:3SXG, ECO:0007744|PDB:3V0L,
FT                   ECO:0007744|PDB:3V0M, ECO:0007744|PDB:3V0O,
FT                   ECO:0007744|PDB:3V0P, ECO:0007744|PDB:3V0Q,
FT                   ECO:0007744|PDB:3ZGG, ECO:0007744|PDB:4C2S,
FT                   ECO:0007744|PDB:4FQW, ECO:0007744|PDB:4FRA,
FT                   ECO:0007744|PDB:4FRB, ECO:0007744|PDB:4FRD,
FT                   ECO:0007744|PDB:4FRE, ECO:0007744|PDB:4FRH,
FT                   ECO:0007744|PDB:4FRL, ECO:0007744|PDB:4FRM,
FT                   ECO:0007744|PDB:4FRO, ECO:0007744|PDB:4FRP,
FT                   ECO:0007744|PDB:4FRQ, ECO:0007744|PDB:4GBP,
FT                   ECO:0007744|PDB:4KC1, ECO:0007744|PDB:4KC2,
FT                   ECO:0007744|PDB:4KC4"
FT   BINDING         326
FT                   /ligand="an alpha-L-fucosyl-(1->2)-beta-D-galactosyl
FT                   derivative"
FT                   /ligand_id="ChEBI:CHEBI:140327"
FT                   /evidence="ECO:0000269|PubMed:12972418,
FT                   ECO:0000269|PubMed:16326711, ECO:0007744|PDB:1R7T,
FT                   ECO:0007744|PDB:1ZI4, ECO:0007744|PDB:1ZI5,
FT                   ECO:0007744|PDB:1ZJ2, ECO:0007744|PDB:1ZJ3,
FT                   ECO:0007744|PDB:2RIY, ECO:0007744|PDB:2RJ1,
FT                   ECO:0007744|PDB:2RJ4, ECO:0007744|PDB:2RJ6,
FT                   ECO:0007744|PDB:2RJ7, ECO:0007744|PDB:2RJ8,
FT                   ECO:0007744|PDB:2RJ9, ECO:0007744|PDB:3V0M,
FT                   ECO:0007744|PDB:3V0O, ECO:0007744|PDB:3V0P,
FT                   ECO:0007744|PDB:3V0Q, ECO:0007744|PDB:4C2S,
FT                   ECO:0007744|PDB:4KC1, ECO:0007744|PDB:4KC2,
FT                   ECO:0007744|PDB:4KC4"
FT   CARBOHYD        113
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VARIANT         35
FT                   /note="G -> R (in dbSNP:rs8176696)"
FT                   /evidence="ECO:0000269|Ref.9"
FT                   /id="VAR_019147"
FT   VARIANT         36
FT                   /note="V -> F (in dbSNP:rs688976)"
FT                   /evidence="ECO:0000269|Ref.9"
FT                   /id="VAR_019148"
FT   VARIANT         63
FT                   /note="R -> H (in dbSNP:rs549446)"
FT                   /evidence="ECO:0000269|Ref.9"
FT                   /id="VAR_019149"
FT   VARIANT         74
FT                   /note="P -> S (in dbSNP:rs512770)"
FT                   /evidence="ECO:0000269|PubMed:12829588, ECO:0000269|Ref.9"
FT                   /id="VAR_019150"
FT   VARIANT         80..81
FT                   /note="CR -> W"
FT                   /id="VAR_003408"
FT   VARIANT         156
FT                   /note="P -> L (in allele A2; dbSNP:rs1053878)"
FT                   /evidence="ECO:0000269|PubMed:12829588,
FT                   ECO:0000269|PubMed:7598760, ECO:0000269|PubMed:8839869,
FT                   ECO:0000269|Ref.5, ECO:0000269|Ref.9"
FT                   /id="VAR_003409"
FT   VARIANT         161
FT                   /note="R -> H (in dbSNP:rs8176738)"
FT                   /evidence="ECO:0000269|Ref.9"
FT                   /id="VAR_019151"
FT   VARIANT         163
FT                   /note="T -> M (in allele Aw08; dbSNP:rs55756402)"
FT                   /evidence="ECO:0000269|PubMed:12829588"
FT                   /id="VAR_036738"
FT   VARIANT         176
FT                   /note="R -> G (in allele Aw08 and allele Bw08;
FT                   dbSNP:rs7853989)"
FT                   /evidence="ECO:0000269|PubMed:12829588,
FT                   ECO:0000269|PubMed:15104652, ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:8839869, ECO:0000269|Ref.15,
FT                   ECO:0000269|Ref.5, ECO:0000269|Ref.9"
FT                   /id="VAR_003410"
FT   VARIANT         198
FT                   /note="R -> W (in allele Aw07)"
FT                   /evidence="ECO:0000269|PubMed:12829588"
FT                   /id="VAR_036739"
FT   VARIANT         199
FT                   /note="R -> C (in dbSNP:rs8176739)"
FT                   /evidence="ECO:0000269|Ref.9"
FT                   /id="VAR_019152"
FT   VARIANT         214
FT                   /note="M -> R (in allele Bel01; loss of manganese binding
FT                   and reduced catalytic activity)"
FT                   /evidence="ECO:0000269|PubMed:17259183,
FT                   ECO:0000269|PubMed:8839869"
FT                   /id="VAR_036740"
FT   VARIANT         216
FT                   /note="F -> I (in dbSNP:rs8176740)"
FT                   /evidence="ECO:0000269|PubMed:8839869, ECO:0000269|Ref.9"
FT                   /id="VAR_019153"
FT   VARIANT         223
FT                   /note="E -> D (in allele B106)"
FT                   /evidence="ECO:0000269|PubMed:8839869"
FT                   /id="VAR_036741"
FT   VARIANT         230
FT                   /note="G -> R (in group B transferase; lower-level protein
FT                   expression and intracellular cytoplasmic mislocation)"
FT                   /evidence="ECO:0000269|PubMed:18513251"
FT                   /id="VAR_055227"
FT   VARIANT         234
FT                   /note="P -> A (in allele B(A))"
FT                   /evidence="ECO:0000269|PubMed:10462501"
FT                   /id="VAR_072628"
FT   VARIANT         235
FT                   /note="G -> S (in allele Bw08; dbSNP:rs8176743)"
FT                   /evidence="ECO:0000269|PubMed:12829588,
FT                   ECO:0000269|PubMed:15104652, ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:18513251, ECO:0000269|PubMed:8839869,
FT                   ECO:0000269|Ref.15, ECO:0000269|Ref.5, ECO:0000269|Ref.9"
FT                   /id="VAR_003411"
FT   VARIANT         257
FT                   /note="P -> L (in dbSNP:rs8176745)"
FT                   /id="VAR_033540"
FT   VARIANT         266
FT                   /note="L -> M (in allele Bw08; dbSNP:rs8176746)"
FT                   /evidence="ECO:0000269|PubMed:12829588,
FT                   ECO:0000269|PubMed:1449469, ECO:0000269|PubMed:15104652,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:18513251,
FT                   ECO:0000269|PubMed:8839869, ECO:0000269|Ref.5,
FT                   ECO:0000269|Ref.9"
FT                   /id="VAR_003412"
FT   VARIANT         268
FT                   /note="G -> A (in allele Bw08; dbSNP:rs8176747)"
FT                   /evidence="ECO:0000269|PubMed:12829588,
FT                   ECO:0000269|PubMed:1449469, ECO:0000269|PubMed:15104652,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:18513251,
FT                   ECO:0000269|PubMed:8839869, ECO:0000269|Ref.9"
FT                   /id="VAR_003413"
FT   VARIANT         268
FT                   /note="G -> R (in allele Aw08; dbSNP:rs41302905)"
FT                   /evidence="ECO:0000269|PubMed:12829588"
FT                   /id="VAR_033541"
FT   VARIANT         277
FT                   /note="V -> M (in dbSNP:rs8176748)"
FT                   /evidence="ECO:0000269|PubMed:8839869, ECO:0000269|Ref.9"
FT                   /id="VAR_019154"
FT   VARIANT         288
FT                   /note="M -> R"
FT                   /evidence="ECO:0000269|PubMed:12829588"
FT                   /id="VAR_036742"
FT   VARIANT         291
FT                   /note="D -> N (in allele B104)"
FT                   /evidence="ECO:0000269|PubMed:8839869"
FT                   /id="VAR_036743"
FT   VARIANT         346
FT                   /note="K -> M (in allele Bw08)"
FT                   /evidence="ECO:0000269|PubMed:12829588, ECO:0000269|Ref.15"
FT                   /id="VAR_036744"
FT   VARIANT         352
FT                   /note="R -> G (in allele A107)"
FT                   /evidence="ECO:0000269|PubMed:8839869"
FT                   /id="VAR_036745"
FT   VARIANT         352
FT                   /note="R -> W (in allele A106 and allele B3)"
FT                   /evidence="ECO:0000269|PubMed:8839869"
FT                   /id="VAR_003414"
FT   MUTAGEN         214
FT                   /note="M->T,V: Alters substrate specificity so that both
FT                   UDP-N-acetyl-D-galactosamine and UDP-galactose are
FT                   utilized."
FT                   /evidence="ECO:0000269|PubMed:17259183"
FT   MUTAGEN         234
FT                   /note="P->S: Alters substrate specificity of group B
FT                   transferase."
FT   MUTAGEN         303
FT                   /note="E->A: Decreases specific activity of group B
FT                   transferase almost to zero."
FT                   /evidence="ECO:0000269|PubMed:12198488"
FT   STRAND          82..84
FT                   /evidence="ECO:0007829|PDB:6GX2"
FT   STRAND          93..95
FT                   /evidence="ECO:0007829|PDB:6GX2"
FT   HELIX           102..111
FT                   /evidence="ECO:0007829|PDB:6GX2"
FT   STRAND          115..122
FT                   /evidence="ECO:0007829|PDB:6GX2"
FT   HELIX           124..129
FT                   /evidence="ECO:0007829|PDB:6GX2"
FT   HELIX           130..140
FT                   /evidence="ECO:0007829|PDB:6GX2"
FT   STRAND          145..154
FT                   /evidence="ECO:0007829|PDB:6GX2"
FT   HELIX           156..158
FT                   /evidence="ECO:0007829|PDB:6GX2"
FT   STRAND          168..174
FT                   /evidence="ECO:0007829|PDB:6GX2"
FT   HELIX           181..198
FT                   /evidence="ECO:0007829|PDB:6GX2"
FT   HELIX           200..203
FT                   /evidence="ECO:0007829|PDB:6GX2"
FT   STRAND          205..210
FT                   /evidence="ECO:0007829|PDB:6GX2"
FT   STRAND          212..216
FT                   /evidence="ECO:0007829|PDB:6GX2"
FT   HELIX           222..224
FT                   /evidence="ECO:0007829|PDB:6GX2"
FT   STRAND          226..232
FT                   /evidence="ECO:0007829|PDB:6GX2"
FT   TURN            234..238
FT                   /evidence="ECO:0007829|PDB:6GX2"
FT   HELIX           241..243
FT                   /evidence="ECO:0007829|PDB:6GX2"
FT   STRAND          269..273
FT                   /evidence="ECO:0007829|PDB:6GX2"
FT   HELIX           274..293
FT                   /evidence="ECO:0007829|PDB:6GX2"
FT   HELIX           301..312
FT                   /evidence="ECO:0007829|PDB:6GX2"
FT   STRAND          316..319
FT                   /evidence="ECO:0007829|PDB:6GX2"
FT   HELIX           321..323
FT                   /evidence="ECO:0007829|PDB:6GX2"
FT   HELIX           327..330
FT                   /evidence="ECO:0007829|PDB:6GX2"
FT   STRAND          341..343
FT                   /evidence="ECO:0007829|PDB:6GX2"
FT   HELIX           348..351
FT                   /evidence="ECO:0007829|PDB:6GX2"
SQ   SEQUENCE   354 AA;  40934 MW;  A03DA16E630C1608 CRC64;
     MAEVLRTLAG KPKCHALRPM ILFLIMLVLV LFGYGVLSPR SLMPGSLERG FCMAVREPDH
     LQRVSLPRMV YPQPKVLTPC RKDVLVVTPW LAPIVWEGTF NIDILNEQFR LQNTTIGLTV
     FAIKKYVAFL KLFLETAEKH FMVGHRVHYY VFTDQPAAVP RVTLGTGRQL SVLEVRAYKR
     WQDVSMRRME MISDFCERRF LSEVDYLVCV DVDMEFRDHV GVEILTPLFG TLHPGFYGSS
     REAFTYERRP QSQAYIPKDE GDFYYLGGFF GGSVQEVQRL TRACHQAMMV DQANGIEAVW
     HDESHLNKYL LRHKPTKVLS PEYLWDQQLL GWPAVLRKLR FTAVPKNHQA VRNP
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024